Ronald Andrews

2019

In 2019, Ronald Andrews earned a total compensation of $2.1M as President and Chief Executive Officer at Oncocyte Corp.

Compensation breakdown

Option Awards$1,626,562
Salary$276,250
Stock Awards$163,150
Total$2,065,962

Andrews received $1.6M in option awards, accounting for 79% of the total pay in 2019.

Andrews also received $276.3K in salary and $163.2K in stock awards.

Rankings

In 2019, Ronald Andrews' compensation ranked 5,768th out of 13,971 executives tracked by ExecPay. In other words, Andrews earned more than 58.7% of executives.

ClassificationRankingPercentile
All
5,768
out of 13,971
59th
Division
Manufacturing
2,159
out of 5,701
62nd
Major group
Chemicals And Allied Products
778
out of 2,200
65th
Industry group
Drugs
655
out of 1,886
65th
Industry
In Vitro and In Vivo Diagnostic Substances
14
out of 77
82nd
Source: SEC filing on May 26, 2020.

Andrews' colleagues

We found five more compensation records of executives who worked with Ronald Andrews at Oncocyte Corp in 2019.

2019

William Annett

Oncocyte Corp

Chief Executive Officer

2019

Lyndal Hesterberg

Oncocyte Corp

Chief Scientific Officer

2019

Mitchell Levine

Oncocyte Corp

Chief Financial Officer

2019

Albert Parker

Oncocyte Corp

Chief Operating Officer

2019

Padma Sundar

Oncocyte Corp

Senior Vice President, Marketing and Market Access

News

In-depth

You may also like